# HELIO Liver Test Performance Study in China (HEPATIC)

> **NCT05053412** · — · COMPLETED · sponsor: **Helio Genomics** · enrollment: 1556 (actual)

## Conditions studied

- Hepatocellular Carcinoma and Liver Disease

## Interventions

- **DIAGNOSTIC_TEST:** Helio Liver Test

## Key facts

- **NCT ID:** NCT05053412
- **Lead sponsor:** Helio Genomics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-05-31
- **Target enrollment:** 1556 (ACTUAL)
- **Last updated:** 2024-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05053412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05053412, "HELIO Liver Test Performance Study in China (HEPATIC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05053412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*